COVID-19 Drug Associated APIs Global Market Report 2025

COVID-19 Drug Associated APIs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on covid-19 drug associated apis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for covid-19 drug associated apis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The covid-19 drug associated apis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Drug Class: Antimalarials; Bronchodilators; Antibiotics; Antivirals; Other Drug Class

2) By Synthesis Type: Synthetic; Biotech

3) By Business Mode: Captive API; Merchant API

Subsegments:

1) By Antimalarials: Hydroxychloroquine; Chloroquine

2) By Bronchodilators: Beta-Agonists; Anticholinergics

3) By Antibiotics: Macrolides; Tetracyclines

4) By Antivirals: Remdesivir; Favipiravir; Lopinavir Or Ritonavir

5) By Other Drug Classes: Corticosteroids; Immunomodulators

Companies Mentioned: Dr. Reddy's Laboratories Ltd.; Lianyungang Guike Pharmaceutical CO. LTD.; Alembic Pharmaceuticals Ltd.; Wockhardt Ltd.; Sandoz Srl

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. COVID-19 Drug Associated APIs Market Characteristics
3. COVID-19 Drug Associated APIs Market Trends And Strategies
4. COVID-19 Drug Associated APIs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global COVID-19 Drug Associated APIs Growth Analysis And Strategic Analysis Framework
5.1. Global COVID-19 Drug Associated APIs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global COVID-19 Drug Associated APIs Market Growth Rate Analysis
5.4. Global COVID-19 Drug Associated APIs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global COVID-19 Drug Associated APIs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global COVID-19 Drug Associated APIs Total Addressable Market (TAM)
6. COVID-19 Drug Associated APIs Market Segmentation
6.1. Global COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Antimalarials
Bronchodilators
Antibiotics
Antivirals
Other Drug Class
6.2. Global COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Synthetic
Biotech
6.3. Global COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Captive API
Merchant API
6.4. Global COVID-19 Drug Associated APIs Market, Sub-Segmentation Of Antimalarials, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hydroxychloroquine
Chloroquine
6.5. Global COVID-19 Drug Associated APIs Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Beta-Agonists
Anticholinergics
6.6. Global COVID-19 Drug Associated APIs Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Macrolides
Tetracyclines
6.7. Global COVID-19 Drug Associated APIs Market, Sub-Segmentation Of Antivirals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Remdesivir
Favipiravir
Lopinavir Or Ritonavir
6.8. Global COVID-19 Drug Associated APIs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Corticosteroids
Immunomodulators
7. COVID-19 Drug Associated APIs Market Regional And Country Analysis
7.1. Global COVID-19 Drug Associated APIs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global COVID-19 Drug Associated APIs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific COVID-19 Drug Associated APIs Market
8.1. Asia-Pacific COVID-19 Drug Associated APIs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China COVID-19 Drug Associated APIs Market
9.1. China COVID-19 Drug Associated APIs Market Overview
9.2. China COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India COVID-19 Drug Associated APIs Market
10.1. India COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan COVID-19 Drug Associated APIs Market
11.1. Japan COVID-19 Drug Associated APIs Market Overview
11.2. Japan COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia COVID-19 Drug Associated APIs Market
12.1. Australia COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia COVID-19 Drug Associated APIs Market
13.1. Indonesia COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea COVID-19 Drug Associated APIs Market
14.1. South Korea COVID-19 Drug Associated APIs Market Overview
14.2. South Korea COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe COVID-19 Drug Associated APIs Market
15.1. Western Europe COVID-19 Drug Associated APIs Market Overview
15.2. Western Europe COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK COVID-19 Drug Associated APIs Market
16.1. UK COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany COVID-19 Drug Associated APIs Market
17.1. Germany COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France COVID-19 Drug Associated APIs Market
18.1. France COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy COVID-19 Drug Associated APIs Market
19.1. Italy COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain COVID-19 Drug Associated APIs Market
20.1. Spain COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe COVID-19 Drug Associated APIs Market
21.1. Eastern Europe COVID-19 Drug Associated APIs Market Overview
21.2. Eastern Europe COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia COVID-19 Drug Associated APIs Market
22.1. Russia COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America COVID-19 Drug Associated APIs Market
23.1. North America COVID-19 Drug Associated APIs Market Overview
23.2. North America COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA COVID-19 Drug Associated APIs Market
24.1. USA COVID-19 Drug Associated APIs Market Overview
24.2. USA COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada COVID-19 Drug Associated APIs Market
25.1. Canada COVID-19 Drug Associated APIs Market Overview
25.2. Canada COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America COVID-19 Drug Associated APIs Market
26.1. South America COVID-19 Drug Associated APIs Market Overview
26.2. South America COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil COVID-19 Drug Associated APIs Market
27.1. Brazil COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East COVID-19 Drug Associated APIs Market
28.1. Middle East COVID-19 Drug Associated APIs Market Overview
28.2. Middle East COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa COVID-19 Drug Associated APIs Market
29.1. Africa COVID-19 Drug Associated APIs Market Overview
29.2. Africa COVID-19 Drug Associated APIs Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa COVID-19 Drug Associated APIs Market, Segmentation By Synthesis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa COVID-19 Drug Associated APIs Market, Segmentation By Business Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. COVID-19 Drug Associated APIs Market Competitive Landscape And Company Profiles
30.1. COVID-19 Drug Associated APIs Market Competitive Landscape
30.2. COVID-19 Drug Associated APIs Market Company Profiles
30.2.1. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Lianyungang Guike Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Alembic Pharmaceuticals Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Wockhardt Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Sandoz Srl Overview, Products and Services, Strategy and Financial Analysis
31. COVID-19 Drug Associated APIs Market Other Major And Innovative Companies
31.1. Lupin Limited
31.2. Aurobindo Pharma Ltd.
31.3. Shanghai Shyndec Pharmaceutical Co. Ltd.
31.4. Zhejiang Yatai Pharmaceutical Co. Ltd.
31.5. Zhejiang Guobang Pharmaceutical Co. Ltd.
31.6. Cipla Limited
31.7. Shandong Boyuan Pharmaceutical Co. Ltd.
31.8. Aspiro Pharma Ltd.
31.9. Qilu Antibiotics Pharmaceutical Co. Ltd.
31.10. Shenzhen China Resources Jiuxin Pharmaceutical Co. Ltd.
31.11. Zhejiang Cheng Yi Pharmaceutical
31.12. Star Lake Bioscience Co. Inc.
31.13. Hetero Labs Ltd.
31.14. Geno Pharmaceuticals Ltd.
31.15. Mylan Laboratories Ltd.
32. Global COVID-19 Drug Associated APIs Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The COVID-19 Drug Associated APIs Market
34. Recent Developments In The COVID-19 Drug Associated APIs Market
35. COVID-19 Drug Associated APIs Market High Potential Countries, Segments and Strategies
35.1 COVID-19 Drug Associated APIs Market In 2029 - Countries Offering Most New Opportunities
35.2 COVID-19 Drug Associated APIs Market In 2029 - Segments Offering Most New Opportunities
35.3 COVID-19 Drug Associated APIs Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings